Cargando…

1499. Tesamorelin Reduces Visceral Adipose Tissue and Liver Fat in INSTI-Treated Persons with HIV

BACKGROUND: Significant attention surrounds the recent observation of weight gain in persons with HIV (PWH) initiating integrase inhibitors (INSTIs). Given the finding that visceral adipose tissue (VAT) is a critical component of this weight gain, the clinical implications of this weight gain are a...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLaughlin, Taryn, Grinspoon, Steven K, Stanley, Takara, Fourman, Lindsay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678288/ http://dx.doi.org/10.1093/ofid/ofad500.1334

Ejemplares similares

Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
por: Fourman, Lindsay T., et al.
Publicado: (2020)

Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach
por: Fourman, Lindsay T., et al.
Publicado: (2021)

Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial
por: Rahman, Farah, et al.
Publicado: (2022)

Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV
por: Fourman, Lindsay T., et al.
Publicado: (2019)

Differential relationships of hepatic and epicardial fat to body composition in HIV
por: Fourman, Lindsay T., et al.
Publicado: (2017)

SAT-256 Obesity and Reactive Airway Disease Are Increased Among HIV-Exposed Uninfected Adolescents
por: Fourman, Lindsay, et al.
Publicado: (2019)

Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo, Roger
Publicado: (2011)

Tesamorelin: A hope for ART-induced lipodystrophy
por: Patel, Akash, et al.
Publicado: (2011)

Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat
por: Mangili, Alexandra, et al.
Publicado: (2015)

Fray Bernardino de Sahagún, 1499-1590 /
por: Nicolau D'Olwer, Lluís, 1888-1961
Publicado: (1952)

2492. Differences between Individuals Currently Taking Integrase Inhibitor (INSTI)-based Therapy and Those Not Taking INSTIs in the Era of INSTIs as Recommended First-line Therapy
por: Monroe, Anne K, et al.
Publicado: (2019)

RF12 | PSUN104 Visceral adiposity index as a measure of cardiometabolic disease in persons living with HIV
por: Thomas, Teressa Sumy, et al.
Publicado: (2022)

935. Effect of Tesamorelin in People with HIV with and without Dorsocervical Fat: Post Hoc Analysis of Phase III Double Blind Placebo Control Trial
por: Rahman, Farah, et al.
Publicado: (2020)

P1499: GENETIC FACTORS OF IRON OVERLOAD IN HEREDITARY SPHEROCYTOSIS
por: Donaty, Lucie, et al.
Publicado: (2023)

Selected CNS Outcomes Among INSTI Antiretrovirals
por: Wohl, David, et al.
Publicado: (2017)

The Emergence of Resistance Under Firstline INSTI Regimens
por: Xie, Zhiman, et al.
Publicado: (2022)

Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus
por: Thomas, Teressa S, et al.
Publicado: (2023)

Visceral and subcutaneous adipose tissue FDG uptake by PET/CT in metabolically healthy obese subjects
por: Oliveira, Adriana L., et al.
Publicado: (2014)

1566. Determinants associated with weight gain among persons with HIV who switch to integrase strand transfer inhibitors (INSTI)
por: Cutshaw, Melissa Klein, et al.
Publicado: (2023)

Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV
por: Dow, Dorothy E., et al.
Publicado: (2014)

1499. Gonorrhea and Chlamydia Infections in the Department of Veterans Affairs (VA), 2013–2017
por: Schirmer, Patricia, et al.
Publicado: (2018)

1563. Incidence of Errors in an INSTI-Based Era: A Comparison of Error Rates Between Single Versus Multiple Tablet INSTI-Based Regimens in the Inpatient Setting
por: Blackmon, Kayla, et al.
Publicado: (2023)

Performance and usability evaluation of the INSTI HIV self-test in Kenya for qualitative detection of antibodies to HIV
por: Bwana, Priska, et al.
Publicado: (2018)

OR15-04 Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure
por: Ockene, Mollie W, et al.
Publicado: (2023)

Syphilis in Maria Salviati (1499–1543), Wife of Giovanni de’ Medici of the Black Bands
Publicado: (2020)

Syphilis in Maria Salviati (1499–1543), Wife of Giovanni de’ Medici of the Black Bands
por: Fornaciari, Antonio, et al.
Publicado: (2020)

Invalid Results in the GetaKit Study in Ottawa: A Real-World Observation of the INSTI® HIV Self-test Among Persons At Risk for HIV
por: O'Byrne, Patrick, et al.
Publicado: (2022)

Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan
por: Chang, Sui-Yuan, et al.
Publicado: (2016)

Relationship Between Neck Circumference and Cardiometabolic Parameters in HIV-Infected and non–HIV-Infected Adults
por: Fitch, Kathleen V., et al.
Publicado: (2011)

Adipose-Tissue and Intestinal Inflammation – Visceral Obesity and Creeping Fat
por: Kredel, Lea I., et al.
Publicado: (2014)

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk
por: Amato, Marco C., et al.
Publicado: (2010)

1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections
por: Kyung Yoon, Young, et al.
Publicado: (2019)

1499. Incidence of Community Acquired Pneumonia by Age and Comorbid Conditions in the Veterans Health Administration (VHA)
por: Bej, Taissa A, et al.
Publicado: (2020)

Is Metabolic Score for Visceral Fat (METS-VF) a Better Index Than Other Adiposity Indices for the Prediction of Visceral Adiposity
por: Torun, Cundullah, et al.
Publicado: (2023)

Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence In Vitro
por: Acosta, Rima K., et al.
Publicado: (2022)

A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
por: Zhao, Alexa Vyain, et al.
Publicado: (2022)

Growth Hormone Releasing Hormone Reduces Plasma Markers of Immune Activation and Hepatic Immune Pathways in Nonalcoholic Fatty Liver Disease
por: Stanley, Takara Leah, et al.
Publicado: (2021)

Safety and efficacy of pharmacotherapy containing INSTIs and chemotherapy drugs in people living with HIV and concomitant colorectal cancer
por: Yang, Jing, et al.
Publicado: (2022)

First report of c. 1499G>C mutation in a 6-month-child with cystic fibrosis
por: Sahami, Abbas, et al.
Publicado: (2014)

The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat
por: Lind, Lars, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ndr5lgri8i8bog9m1g567pp53e